{"id":"W3119100447","doi":"10.1186/s12885-020-07538-1","title":"Comparative efficacy and safety of adjuvant nivolumab versus other treatments in adults with resected melanoma: a systematic literature review and network meta-analysis","year":2021,"lang":"en","type":"review","venue":"BMC Cancer","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"MD Precision (Canada)","funders":"Bristol-Myers Squibb","keywords":"Medicine; Nivolumab; Ipilimumab; Internal medicine; Dabrafenib; Oncology; Adjuvant; Hazard ratio; Adverse effect; Trametinib; Randomized controlled trial; Adjuvant therapy; Melanoma; Meta-analysis; Confidence interval; Cancer; Immunotherapy; Vemurafenib; Metastatic melanoma; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01871516,0.002188928,0.01432147,0.006735458,0.0004092884,0.002563743,0.001830388,0.00181419,0.003044413],"category_scores_gemma":[0.04094902,0.00125693,0.03737155,0.006533456,0.0005863028,0.00147471,0.001383269,0.001691832,0.0002908045],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002401234,"about_ca_system_score_gemma":0.002921245,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005754264,"about_ca_topic_score_gemma":0.01064918,"domain_scores_codex":[0.9854827,0.008051939,0.003576026,0.001442173,0.00116321,0.0002839431],"domain_scores_gemma":[0.9722258,0.02092709,0.004479244,0.0007254839,0.001382813,0.0002596558],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.002106299,0.00002933524,0.005037158,0.2237188,0.7587869,0.00007423427,0.00005642536,0.0008470875,0.0001520667,0.0001413536,0.000366958,0.008683329],"study_design_scores_gemma":[0.0006823674,0.0001898394,0.003399814,0.01511939,0.9789306,0.00005603545,0.00002494731,0.0003297475,0.00006682324,0.0002257417,0.0009563092,0.00001840863],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01141199,0.9846532,0.001236813,0.0003575477,0.00015886,0.0004564432,0.001232904,0.00002988617,0.0004622435],"genre_scores_gemma":[0.3954926,0.5943421,0.004305746,0.001297541,0.0003126166,0.001805226,0.002056163,0.00004672421,0.0003412952],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01871516,"threshold_uncertainty_score":0.09897637,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.087583609757823,"score_gpt":0.3658277947123378,"score_spread":0.2782441849545149,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}